Literature DB >> 13216788

The uptake of radioactive phosphorus by intraocular neoplasms.

E B DUNPHY, K K DREISLER, J B CADIGAN, W SWEET.   

Abstract

Entities:  

Keywords:  EYE/neoplasms; PHOSPHORUS/radioactive

Mesh:

Substances:

Year:  1953        PMID: 13216788      PMCID: PMC1312570     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  7 in total

1.  Clinical and Experimental Studies of Fluorescein Dyes with Special Reference to their Use for the Diagnosis of Central Nervous System Tumors.

Authors:  G E Moore; S W Hunter; T B Hubbard
Journal:  Ann Surg       Date:  1949-10       Impact factor: 12.969

2.  Use of Radioactive Diiodofluorescein in the Diagnosis and Localization of Brain Tumors.

Authors:  G E Moore
Journal:  Science       Date:  1948-05-28       Impact factor: 47.728

3.  Radio-active di-iodofluorescein in the diagnosis of intra-ocular tumours.

Authors:  P D TREVOR-ROPER; K A NEWTON; J P NICHOLSON
Journal:  Br J Ophthalmol       Date:  1952-10       Impact factor: 4.638

4.  Detection of intraocular tumors with radioactive phosphorus; a preliminary report with special reference to differentiation of the cause of retinal separation.

Authors:  C I THOMAS; J S KROHMER; J P STORAASLI
Journal:  AMA Arch Ophthalmol       Date:  1952-03

5.  Radiophosphorus (P32) in diagnosis and treatment.

Authors:  B J DUFFY; J W HOWLAND
Journal:  N Y State J Med       Date:  1952-03-01

6.  The uses of nuclear disintegration in the diagnosis and treatment of brain tumor.

Authors:  W H SWEET
Journal:  N Engl J Med       Date:  1951-12-06       Impact factor: 91.245

7.  Surface Measurements of Radioactive Phosphorus in Breast Tumors as a Possible Diagnostic Method.

Authors:  B V Low-Beer
Journal:  Science       Date:  1946-10-25       Impact factor: 47.728

  7 in total
  1 in total

Review 1.  The 32P test and other methods in the diagnosis of intraocular tumors. (Thesis).

Authors:  R A Van Dijk
Journal:  Doc Ophthalmol       Date:  1978-10-16       Impact factor: 2.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.